Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...

French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...

The Indicator from Planet Money A little show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening today. It's a quick hit of insight into ...

2 Auxiliary Fuel Tanks (ACTs) for over 4000 nm of range non-stop (Middle East to Europe - Europe to US East Coast – Asia to Middle East) ...